Restenosis is a complex disease for which the pathophysiological mechanisms have not yet
been fully elucidated, but are thought to include inflammation, proliferation, and matrix …

Despite the introduction of drug-eluting stents to combat the neointimal hyperplasia that
occurred after BMS implantation, in-stent restenosis is still encountered in a significant …

Objectives This study conducted detailed analysis of calcified culprit plaques in patients with
acute coronary syndromes (ACS). Background Calcified plaques as an underlying …

Objectives: The present study aimed to analyze the incidence of SF and its correlation with
clinical events after DES implantation and the outcome of re-intervention for symptomatic in …

Background—Stent fracture (SF) after drug-eluting stent implantation has recently become
an important concern because of its potential association with in-stent restenosis and stent …

In general, the fracture resistance of a stent is influenced by multiple factors, including
features of the stent, its delivery and deployment, the vessel into which it is implanted, and …

In-stent restenosis (ISR) remains a significant limitation despite the considerable previous
clinical and investigative emphasis on the problem. Complications arising from the …

Introduction: In-stent restenosis (ISR) has been one of the biggest limitations to the success
of percutaneous coronary intervention for the treatment of coronary artery disease (CAD) …

Stent fracture has been recognized as one cause of stent failure and has been associated
with in-stent restenosis and stent thrombosis, even in 2nd-generation drug-eluting stents …

Although reported in bare metal stents (BMS) and first-generation drug-eluting stents (DES),
little is known about neoatherosclerosis in second-generation DES. We used optical …